这是演示店铺,请务下单付款,避免造成你的财物损失。

为了获得访问"阿拉丁铁蛋"实时聊天框的流畅支持体验,建议您使用Chrome浏览器或选择360浏览器极速模式(如何切换极速模式?),感谢您选择我们!

卡培他滨

5-氟尿嘧啶前药。抗癌剂。
规格或纯度: ≥99%
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
C124969-250mg
250mg 现货 Stock Image
C124969-1g
1g 现货 Stock Image
C124969-5g
5g 现货 Stock Image
C124969-25g
25g 现货 Stock Image
C124969-100g
100g 现货 Stock Image

基本描述

别名 5′-脱氧-5-氟-N-[(戊氧基)羰基]胞苷
英文别名 Ro-9-1978;5′-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine;5'-Deoxy-5-fluoro-N⁴-[(pentyloxy)carbonyl]cytidine
规格或纯度 ≥99%
英文名称 Capecitabine
生化机理 Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrμg, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. The activation of capecitabine follows a pathway with three enzymatic steps and two intermediary metabolites, 5'-deoxy-5-fluorocytidine (5'-DFCR) and 5'-deoxy-5-fluorouridine (5'-DFUR), to form 5-fluorouracil. From Wikipedia.Selective, novel oral fluoropyrimidine carbamate. Prodrug of 5-Fluorouracil . Anticancer agent. Active in vitro and in vivo .
应用 An antiproliferative 5-fluorouracil releasing compound
储存温度 -20°C储存
运输条件 超低温冰袋运输
备注 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。有毒,请参阅SDS以获取更多信息。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。
产品介绍

Capecitabine是一种治疗肿瘤选择性的氟嘧啶氨基甲酸酯,具有较高的瘤内5-FU水平,且毒性比5-FU低。An antiproliferative 5-fluorouracil releasing compound

Capecitabine is a tumor-selective fluoropyrimidine carbamate which achieves higher intratumoral 5-FU level with lower toxicity than 5-FU.
An antiproliferative 5-fluorouracil releasing compound

名称和标识符

PubChem SID 488183411
IUPAC Name pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate
INCHI InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1
InChi Key GAGWJHPBXLXJQN-UORFTKCHSA-N
Canonical SMILES CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O
WGK Germany 3
关联CAS 154361-50-9
PubChem CID 60953
MeSH Entry Terms capecitabine;N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine;Xeloda
分子量 359.35

化学和物理性质

溶解性 Soluble in water (26 mg/ml), ethanol (207 mg/ml), methanol (> 40%), DMF (~14 mg/ml), and DMSO (72 mg/ml at 25 °C).
敏感性 对热敏感
比旋光度 98° (C=1,MeOH)
熔点 123 °C(dec.)

安全和危险性(GHS)

象形图
ghs08

Health Hazard

ghs07

Harmful

信号词 Danger
危险声明 H315: Causes skin irritation
H319: Causes serious eye irritation
H341: Suspected of causing genetic defects
H360: May damage fertility or the unborn child
H350: May cause cancer
预防措施声明 P305+P351+P338,P280,P302+P352,P321,P405,P501,P264,P281,P362+P364,P203,P264+P265,P318,P337+P317,P332+P317
WGK Germany 3
Merck Index 1754

质检证书(COA)

质检报告(COA)

输入批号以搜索COA:

相关技术文章

FAQ
核苷类医药中间体应用
Application of nucleoside pharmaceutical intermediates

产品问答

产品问答

登录提交问题 Hover me 请先登录再提交问题
您提交该产品问题后,我们会在1-2个工作日内给您答复,您可以登录"我的账号",然后点击"我的产品问答"查看答案

参考文献

1. Shi H et al..  (2014)  Anti-angiogenesis participates in antitumor effects of metronomic capecitabine on colon cancer..  Cancer Lett,  349  (2):  (128-35).  [PMID:24746899]
2. Miwa M et al..  (1998)  Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue..  Eur J Cancer,  34  (8):  (1274-81).  [PMID:9849491]
3. Terranova-Barberio M et al..  (2015)  Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression..  Oncotarget,    ():  ().  [PMID:26735339]

计算器